Education
About Us
Working with TipRanks
Follow Us
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
IONS Analyst Ratings
Moderate Buy
11 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IONS Stock 12 Month Forecast
Average Price Target
$56.22
▲(107.53% Upside)
| Highest Price Target$78.00 | Average Price Target$56.22 | Lowest Price Target$38.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
Reiterated
04/03/25
Citi
Reiterated
04/03/25
Wells Fargo
Reiterated
04/03/25
Redburn Atlantic
Initiated
03/31/25
J.P. Morgan
Reiterated
03/24/25
Leerink Partners
Reiterated
03/13/25
William Blair
Reiterated
03/12/25
Oppenheimer
Reiterated
03/12/25
Stifel Nicolaus
Reiterated
02/23/25
Bernstein
$51→$43
Hold
58.73%
Upside
Reiterated
02/21/25
Ionis Pharmaceuticals (IONS) PT Lowered to $43 at Bernstein SocGen GroupBernstein SocGen Group analyst William Pickering lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $43.00 (from $51.00) while maintaining a Market Perform rating.
Barclays
$51
Hold
88.26%
Upside
Reiterated
02/20/25
Barclays Remains a Hold on Ionis Pharmaceuticals (IONS)
Raymond James
$61→$60
Buy
121.48%
Upside
Reiterated
02/20/25
Ionis Pharmaceuticals (IONS) PT Lowered to $60 at Raymond JamesRaymond James analyst Gary Nachman lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $60.00 (from $61.00) while maintaining a Strong Buy rating.
Bank of America Securities
$66→$63
Buy
132.56%
Upside
Reiterated
02/19/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ionis Pharmaceuticals (NASDAQ: IONS), Stryker (NYSE: SYK) and Bausch + Lomb Corporation (NYSE: BLCO)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Reiterated
04/03/25
Citi
Reiterated
04/03/25
Wells Fargo
Reiterated
04/03/25
Redburn Atlantic
Initiated
03/31/25
J.P. Morgan
Reiterated
03/24/25
Leerink Partners
Reiterated
03/13/25
William Blair
Reiterated
03/12/25
Oppenheimer
Reiterated
03/12/25
Stifel Nicolaus
Reiterated
02/23/25
Bernstein
$51→$43
Hold
58.73%
Upside
Reiterated
02/21/25
Ionis Pharmaceuticals (IONS) PT Lowered to $43 at Bernstein SocGen GroupBernstein SocGen Group analyst William Pickering lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $43.00 (from $51.00) while maintaining a Market Perform rating.
Barclays
$51
Hold
88.26%
Upside
Reiterated
02/20/25
Barclays Remains a Hold on Ionis Pharmaceuticals (IONS)
Raymond James
$61→$60
Buy
121.48%
Upside
Reiterated
02/20/25
Ionis Pharmaceuticals (IONS) PT Lowered to $60 at Raymond JamesRaymond James analyst Gary Nachman lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $60.00 (from $61.00) while maintaining a Strong Buy rating.
Bank of America Securities
$66→$63
Buy
132.56%
Upside
Reiterated
02/19/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ionis Pharmaceuticals (NASDAQ: IONS), Stryker (NYSE: SYK) and Bausch + Lomb Corporation (NYSE: BLCO)
IONS Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
18
19
21
14
13
Buy
1
2
1
2
1
Hold
6
8
9
12
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
29
31
28
23
Each month's total comprises the sum of three months' worth of ratings.
IONS Financial Forecast
IONS Stock Forecast FAQ
What is IONS’s average 12-month price target, according to analysts?
Based on analyst ratings, Ionis Pharmaceuticals’s 12-month average price target is $56.22.
What is IONS’s upside potential, based on the analysts’ average price target?
Ionis Pharmaceuticals has 107.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IONS a Buy, Sell or Hold?
Ionis Pharmaceuticals has a consensus rating of Moderate Buy which is based on 11 buy ratings, 8 hold ratings and 0 sell ratings.
What is Ionis Pharmaceuticals’s price target?
The average price target for Ionis Pharmaceuticals is $56.22. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $78.00 ,the lowest forecast is $38.00. The average price target represents 107.53% Increase from the current price of $27.09.
The highest analyst price target is $78.00 ,the lowest forecast is $38.00. The average price target represents 107.53% Increase from the current price of $27.09.
What do analysts say about Ionis Pharmaceuticals?
Ionis Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of IONS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.